[1]王心综述,陈铖审校.沉默信息调节因子1对肾间质保护作用的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2018,20(02):177-180.[doi:10.3969/j.issn.1672-271X.2018.02.016]

点击复制

沉默信息调节因子1对肾间质保护作用的研究进展()

分享到62.8K

参考文献/References:

[1]Sinclair DA, Guarente L. Extrachromosomal rDNA circles-a cause of aging in yeast[J]. Cell,1997,91(7):1033-1042.
[2]Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function[J]. Biochem J,2007,404(1):1-13.
[3]赵静姝，王蓉. 沉默信息调节因子2同源体1及其激动剂的神经生物学作用[J]. 医学研究生学报,2011,24(12):1324-1328.
[4]邓展涛，赵云龙，陈烁，等. Stat3基因和 SirT1基因参与类风湿关节炎发病机制的研究进展[J]. 医学研究生学报,2015，28(9):1001-1003.
[5]熊禹真，汪亚君，张海涛. SIRT1抑制高良姜素诱导的HepG2细胞凋亡的研究[J]. 医学研究生学报,2017,30(3):233-239.
[6]Tang K, Sun M, Shen J, et al. Transcriptional Coactivator p300 and Silent Information Regulator 1 (SIRT1) GenePolymorphism Associated with Diabetic Kidney Disease in a Chinese Cohort[J]. Exp Clin Endocrinol Diabetes,2017,125(8):530-537.
[7]刘伟敬，梁碧婵，胡海滢，等. “益气养阴通络法”通过调控SIRT1延缓糖尿病肾病进展的研究[J]. 中国中西医结合肾病杂志,2013，14(3):198-202.
[8]黄新忠，郝传明. 沉默信息调节因子T1与肾脏疾病的研究进展[J]. 中华肾脏病杂志,2011,27(8):625-628.
[9]Gotta M, Strahl-Bolsinger S, Renauld H, et al. Localization of Sir2p: the nucleolus as a compartment for silent information regulators[J]. EMBO J,1997,16(11):3243-3255.
[10]Houtkooper RH, Pirinen E, Auwerx J. Sirtuins as regulators of metabolism and healthspan[J]. Nat Rev Mol Cell Biol,2012,13(4):225-238.
[11]Fan H, Yang HC, You L, et al. The histone deacetylase, SIRT1, contributes to the resistance of young mice to ischemia/reperfusion-induced acute kidney injury[J]. Kidney Int,2013,83(3):404-413.
[12]Simic P, Williams EO, Bell EL, et al. SIRT1 suppresses the epithelial-to-mesenchymal transition in cancer metastasis and organ fibrosis[J]. Cell Rep,2013,3(4):1175-1186.
[13]Gao R, Chen J, Hu Y, et al. Sirt1 deletion leads to enhanced inflammation and aggravates endotoxin-induced acute kidney injury[J]. PLoS One,2014,9(6):e98909.
[14]Qin W, Xie W, Yang X, et al. Inhibiting microRNA-449 Attenuates Cisplatin-Induced Injury in NRK-52E Cells Possibly via Regulating the SIRT1/P53/BAX Pathway[J]. Med Sci Monit,2016,22:818-823.
[15]Hasegawa K, Wakino S, Yoshioka K, et al. Kidney-specific overexpression of Sirt1 protects against acute kidney injury by retaining peroxisome function[J]. J Biol Chem,2010,285(17):13045-13056.
[16]张德兵，李文华，刘娜娜，等. 姜黄素上调Sirt1表达预防对比剂急性肾损伤的实验研究[J]. 医学研究杂志,2016,45(12):133-137, 156.
[17]He L, Peng X, Zhu J, et al. Protective effects of curcumin on acute gentamicin-induced nephrotoxicity in rats[J]. Can J Physiol Pharmacol,2015,93(4):275-282.
[18]李璐，杨晶，张颖，等. SIRT1在小鼠肾缺血再灌注损伤中的作用及其对NF-κBp65-PGC-1α信号通路的影响[J]. 中华肾脏病杂志,2015,31(2):133-139.
[19]Fan H, Yang HC, You L, et al. The histone deacetylase, SIRT1, contributes to the resistance of young mice to ischemia/reperfusion-induced acute kidney injury[J]. Kidney Int,2013,83(3):404-413.
[20]Lempiainen J, Finckenberg P, Mervaala EE, et al. Caloric restriction ameliorates kidney ischaemia/reperfusion injury through PGC-1alpha-eNOS pathway and enhanced autophagy[J]. Acta Physiol (Oxf),2013,208(4):410-421.
[21]杨向红.Sirt1对脓毒症致急性肾损伤保护作用及机制的实验研究[D].杭州:浙江大学博士学位论文，2014.
[22]甘燕子.白藜芦醇对脓毒症大鼠急性肾损伤的保护作用及其对NF-κB p65表达的影响[D].广州:南方医科大学博士学位论文，2016.
[23]Ivanova L, Butt MJ, Matsell DG. Mesenchymal transition in kidney collecting duct epithelial cells[J].Am J Physiol Renal Physiol,2008,294(5):F1238-F1248.
[24]Xiao Z, Chen C, Meng T, et al.Resveratrol attenuates renal injury and fibrosis by inhibiting transforming growth factor-beta pathway on matrix metalloproteinase 7[J]. Exp Biol Med,2016,241(2):140-146.
[25]阳石坤.普罗布考通过P66Shc保护糖尿病肾病肾小管间质损伤的作用及机制研究[D].长沙:中南大学博士学位论文，2014.
[26]Matsui F, Rhee A, Hile KL, et al. IL-18 induces profibrotic renal tubular cell injury via STAT3 activation[J]. Am J Physiol Renal Physiol,2013,305(7):F1014-F1021.
[27]Kim H, Baek CH, Lee RB, et al. Anti-Fibrotic Effect of Losartan, an Angiotensin II Receptor Blocker, Is Mediated through Inhibition of ER Stress via Up-Regulation of SIRT1, Followed by Induction of HO-1 and Thioredoxin[J]. Int J Mol Sci,2017,18(2).
[28]Chang JW, Kim H, Baek CH, et al. Up-Regulation of SIRT1 Reduces Endoplasmic Reticulum Stress and Renal Fibrosis[J]. Nephron,2016,133(2):116-128.
[29]Wu S,Sun G, Hsu C, et al. Tumor necrosis factor-alpha induces epithelial-mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism[J].Exp Biol Med,2011,236(9):1022-1029.
[30]Yuan Y, Chen Y, Zhang P, et al. Mitochondrial dysfunction accounts for aldosterone-induced epithelial-to-mesenchymal transition of renal proximal tubular epithelial cells[J]. Free Radic Biol Med,2012,53(1):30-43.
[31]Zeng XS, Jia JJ, Kwon Y, et al. The role of thioredoxin-1 in suppression of endoplasmic reticulum stress in Parkinson disease[J]. Free Radic Biol Med,2014,67:10-18.
[32]Kim EN, Lim JH, Kim MY, et al. PPARalpha agonist, fenofibrate, ameliorates age-related renal injury[J]. Exp Gerontol,2016,81:42-50.
[33]倪珺.STAT3乙酰化在肾小管上皮细胞功能改变及肾脏纤维化中作用机制的研究[D]. 上海:复旦大学博士学位论文，2014.
[34]Yang SY, Lin SL, Chen YM, et al. Downregulation of angiotensin type 1 receptor and nuclear factor-kappaB by sirtuin 1 contributes to renoprotection in unilateral ureteral obstruction[J]. Sci Rep,2016,6:33705.
[35]Meng XM, Chung AC, Lan HY. Role of the TGF-beta/BMP-7/Smad pathways in renal diseases[J]. Clin Sci (Lond),2013,124(4):243-254.
[36]Wu CF, Chiang WC, Lai CF, et al. Transforming growth factor beta-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis[J]. Am J Pathol,2013,182(1):118-131.
[37]董莉.Sirt1过表达对TGF-β1诱导人肾小管上皮细胞株凋亡的影响及机制研究[D]. 石家庄: 河北医科大学硕士学位论文，2015.
[38]Ren Y, Du C, Shi Y, et al. The Sirt1 activator, SRT1720, attenuates renal fibrosis by inhibiting CTGF and oxidative stress[J]. Int J Mol Med,2017,39(5):1317-1324.
[39]梁瑾.白藜芦醇对肾脏纤维化的保护作用及相关机制研究[D].苏州:苏州大学硕士学位论文，2015.

相似文献/References: